-
Eighteen injections and one inhaler were newly announced
Time of Update: 2020-08-13
in cDE's latest list of reference preparations, covering a number of heavy injection stakes, including injection of volicazole, injection with amoxicillin sodium kravicorate potassium, injection of titacycline, etc., in 2019 China's urban public hospitals, county-level public hospitals, urban community centers and township health hospitals (referred to as China's public medical institutions) terminal sales of more than 2 billion yuan.
-
Fosun pharmaceutical acetaminophen tablets are evaluated for consistency by generics
Time of Update: 2020-08-05
The drug is an anti-TB drug, mainly used in combination with other anti-TB drugs to treat tuberculosis caused by bacillus tuberculosis, but also can be used for the treatment of tuberculosis meningitis and atypical mycobacteria infection.
-
417 drug hospitals are not sold! Mainly because of this reason
Time of Update: 2020-06-26
" Pharmaceutical Network Industry Dynamic " Recently, Shandong Province Public Resources Trading Center issued a notice, 48 products to withdraw the network, 369 drugs suspended trading, a total of
-
Nearly 40 million! A number of well-known pharmaceutical companies transfer varieties of technology, green leaf pharmaceutical, double into the pharmaceutical industry
Time of Update: 2020-06-16
A number of well-known pharmaceutical companies will recently complete the transfer of some products and technology Green Leaf Pharmaceutical transfer 2 varieties of technology June 8, Sichuan Provinc
-
500 million yuan! Five subsidiaries of this pharmaceutical company
Time of Update: 2020-02-20
[pharmaceutical network enterprise news] recently, the actual controller of Laimei pharmaceutical entrusted the voting rights of 184 million shares it held to Zhongheng group, which will control 194 m
-
Global drug market sales of more than $1.5 trillion in 2023, China's pharmaceutical industry is moving towards a "global new
Time of Update: 2020-02-05
Pharmaceutical Network Market Analysis: Due to various factors, the global pharmaceutical industry has achieved rapid development, at the same time, the global pharmaceutical market has also been dev
-
Anhui Province officially announced volume purchases
Time of Update: 2019-12-25
On December 24, 2019, Anhui Provincial Medical centralized purchase service center issued the implementation plan of negotiation and negotiation (pilot) for centralized purchase of some commonly used
-
What will be the situation of China's pharmaceutical equipment industry in 2020? One text prediction
Time of Update: 2019-12-03
[market analysis of pharmaceutical network] in a flash, we have reached the end of 2019 In this critical period, some enterprises are busy summarizing and checking, some are busy planning and making new plans for the next year..
-
Observation on the main clinical therapeutic effect indexes of LVYE pharmaceutical anti-tumor biological drug ly01008 in phase III
Time of Update: 2019-11-04
LVYE Pharmaceutical Group announced that its biological antibody drug ly01008 (Avastin ® biological analogue) in the field of tumor had completed a phase III clinical trial in China in May this year,
-
Can step clinical trial of new drugs be approved by nmpa
Time of Update: 2019-07-05
On July 3, step pharmaceutical announced that the clinical trial application of recombinant human brain natriuretic peptide for injection (project code: bc003) of its holding subsidiary Shandong Danho
-
Disclosure of the salary of the employees of 10 billion revenue pharmaceutical enterprises, more than 170000 yuan in 5 companies
Time of Update: 2019-05-21
[pharmaceutical Station industry trends] it is reported that in 2018, of the 35 A-share pharmaceutical listed companies with revenues of more than 10 billion, 10 companies' employees' per capita salar
-
Mr. Zhang shaori, the actual controller of Zhongsheng pharmaceutical industry, died at the age of 63
Time of Update: 2019-05-06
On the evening of May 5, Zhongsheng Pharmaceutical Co., Ltd announced that Zhang shaori, the actual controller and controlling shareholder of the company, died on May 2 due to invalid medical treatmen
-
[one week] it's settled. The biggest acquisition in history! 48 pharmaceutical companies have invested over 100 million yuan in R & D and 4 companies have invested over 1 billion yuan in R & D; 24
Time of Update: 2019-04-15
BMS, a global pharmaceutical giant, has finally decided to acquire new base! In January 2019, BMS announced a $74 billion acquisition of new base pharmaceuticals However, the deal was strongly opposed
-
How to integrate GSK and Pfizer to establish the largest OTC enterprise in China
Time of Update: 2018-12-20
On December 19, two multinational giants, GKS and Pfizer, officially announced on the official website of their headquarters that GSK and Pfizer would merge their consumer health businesses into a joi
-
This pharmaceutical company has settled the global biological medicine R & D center in Shanghai, further expanding the enabling platform
Time of Update: 2018-11-22
[industry trends of China Pharmaceutical network] on November 22, Yaoming biology announced the official opening of the global innovative bio pharmaceutical R & D and pharmaceutical integration center
